Glen Kwon

About

Professor Glen Kwon holds the Jens T. Carstensen Chair Professorship in Pharmaceutical Sciences and is a Vilas Distinguished Achievement Professor at the University of Wisconsin–Madison. He earned his Bachelor of Science in Chemistry in 1986 and his PhD in Pharmaceutics in 1991, both from the University of Utah. Following his doctoral studies, he completed postdoctoral training in Bioengineering at Tokyo Women's Medical College in 1993. Professor Kwon leads the Kwon Research Group, which is a collaborative team of chemists and biologists, including postdoctoral fellows, undergraduates, and both US and international students. The group is dedicated to groundbreaking pharmaceutical research, emphasizing a collaborative spirit and global competence as essential to advancing science. Located within a top research university, the lab benefits from access to state-of-the-art facilities and equipment, and fosters numerous opportunities for networking and collaboration with the UW School of Medicine and Public Health, other leading R1 universities, and organizations worldwide.

Research topics

• Medicine
• Materials science
• Organic chemistry
• Nanotechnology
• Pharmacology
• Chemistry
• Virology
• Veterinary medicine
• Intensive care medicine
• Polymer chemistry

Selected publications

• Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy

  Advanced Functional Materials · 2021 · 130 citations

  Abstract Immunotherapy is leading a paradigm shift in the treatment of various diseases, including tumors, auto‐immune diseases, and infectious diseases. However, the limited response rate and systemic side effects significantly impede the clinical applications of immunotherapy. As natural carriers for proteins and molecules, cells with low immunogenicity and toxicity have attracted considerable attention for biomedical applications and have achieved encouraging progress especially in immunother…

  DOI

• Gold nanoparticles in virus detection: Recent advances and potential considerations for SARS‐CoV‐2 testing development

  Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 2021 · 76 citations

  Viruses are infectious agents that pose significant threats to plants, animals, and humans. The current coronavirus disease 2019 pandemic, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally and resulted in over 2 million deaths and immeasurable financial losses. Rapid and sensitive virus diagnostics become crucially important in controlling the spread of a pandemic before effective treatment and vaccines are available. Gold nanoparticle (AuNP)-ba…

  PublisherOA PDFDOI

• Production of paclitaxel-loaded PEG-b-PLA micelles using PEG for drug loading and freeze-drying

  Journal of Controlled Release · 2022 · 33 citations

  Senior authorCorresponding
  PublisherOA PDFDOI

• From Conventional to Next-Generation Strategies: Recent Advances in Polymeric Micelle Preparation for Drug Delivery

  Pharmaceutics · 2025-10-21 · 26 citations

  reviewOpen accessSenior authorCorresponding

  Polymeric micelles are promising nanocarriers for hydrophobic drug delivery, offering enhanced solubility, circulation time, and targeted release. This review presents a comprehensive evaluation of micelle preparation strategies, spanning conventional methods such as direct dissolution, dialysis, and thin-film hydration to emerging techniques including microfluidics, supercritical fluids, stimuli-responsive systems, and PEG-assisted assembly. Each method is compared in terms of scalability, repr…

  PublisherOA PDFDOI

• Oligo(Lactic Acid)8-Docetaxel Prodrug-Loaded PEG-b-PLA Micelles for Prostate Cancer

  Nanomaterials · 2021 · 18 citations

  Senior authorCorresponding

  in a preclinical mouse model of prostate cancer.

  PublisherOA PDFDOI

Recent grants

• Oligo(lactic acid)n-Prodrug Nanomedicines for Combination Therapy

  NIH · $1.4M · 2021–2025

• NIH Grant R29AI043346

  NIH · $488k · 2003

• NIH Grant R01AI043346

  NIH · $1.1M · 2012

Frequent coauthors

• John Samuel

  35 shared

• Teruo Okano

  Tokyo Women's Medical University

  26 shared

• Kazunori Kataoka

  Johns Hopkins University

  25 shared

• Anuj Kuldipkumar

  19 shared

• Hyunah Cho

  St. John's University

  19 shared

• Yvonne Tze Fung Tan

  Petronas (Malaysia)

  18 shared

• Geoff G. Z. Zhang

  Purdue University West Lafayette

  17 shared

• Mark Goldstein

  University of Colorado Denver

  16 shared

Labs

• Kwon Research GroupPI

Education

• Ph.D., Pharmaceutical Sciences

  University of Wisconsin–Madison

  2000

• M.S., Pharmaceutical Sciences

  University of Wisconsin–Madison

  1996

• B.S., Pharmaceutical Sciences

  University of Wisconsin–Madison

  1994

Similar researchers at University of Wisconsin-Madison

• Weibo Caih-113
• Jeffrey Johnsonh-109
• Quanyin Huh-95